伏隔核
抗焦虑药
高架加迷宫
焦虑
化学
受体
心理学
方差分析
运动活动
药理学
神经科学
药品
行为绝望测验
内科学
药品管理局
内分泌学
麻醉
剂量依赖性
药物治疗
吞咽不足
全身给药
作者
Kimia Najafi,Yasaman Vakiloroaya,Batool Ghorbani Yekta,Shahrzad Khakpour,Mohadeseh Ghalandari-Shamami
标识
DOI:10.14715/cmb/2025.72.1.1
摘要
Beta-adrenergic receptors are involved in anxiety disorders and help regulate anxiety-like behaviors. The nucleus accumbens (NAc), an important brain structure for emotional regulation and learning, plays a crucial role in anxiety. However, limited research has addressed the specific contribution of the NAc - particularly its noradrenergic mechanisms - in anxiety. This study aimed to investigate the effects of administering different doses of Xamoterol, a partial β1-adrenergic agonist, directly into the NAc shell, to understand its impact on anxiety-related processes and the retrieval of emotional memory. Forty adult male Wistar rats were bilaterally implanted with cannulas targeting the NAc shell. The rats received intra-accumbal Xamoterol at doses of 0.01, 0.1, or 1 μg/1 μl (saline). Five minutes after drug administration, anxiety-like behavior was tested using the Elevated Plus Maze (EPM). Twenty-four hours later, an EPM retention test was conducted to assess emotional memory retrieval. In addition, an open-field test was used to measure spontaneous locomotor activity. One-way ANOVA results showed that intra-accumbal Xamoterol (0.1 and 1 μg) significantly decreased anxiety-like behavior on the EPM. Conversely, head-dipping behavior (a risk assessment measure) was significantly increased at 0.01 and 0.1 μg doses of Xamoterol, which can be interpreted as an anxiolytic effect. Furthermore, higher doses of Xamoterol (0.1 and 1 μg) led to better emotional memory performance compared to the control group. None of the Xamoterol doses produced any significant change in locomotor activity (open-field test). These results suggest that β1-adrenergic receptors in the NAc shell play a role in mediating anxiolytic behavior and enhancing emotional memory retrieval in adult male rats.
科研通智能强力驱动
Strongly Powered by AbleSci AI